سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Login
PapersConferencesJournals

The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA

Publish place: Iranian Journal of Nuclear Medicine، Vol: 26، Issue: 1
Publish Year: 1397
Type: Journal paper
Language: English
View: 477

This Paper With 7 Page And PDF Format Ready To Download

DOWNLOAD Paper

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

Export:

Link to this Paper:
https://civilica.com/doc/986533

Document National Code:

JR_IRJNM-26-1_002

Index date: 10 February 2020

The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA abstract

Prostate-specific membrane antigen (PSMA) is a type II transmembrane protein, which is anchored in the cell membrane of prostate epithelial cells. It is highly expressed on prostate epithelial cells and strongly up-regulated in prostate cancer. Although, 177Lu-PSMA has been recently introduced for radionuclide therapy of metastatic castration-resistant prostate cancer (mCRPC) with continuously increasing interest and use worldwide. This guideline is intended to assist nuclear medicine physicians in evaluating and managing patients with mRCPC for whom radioligand therapy (RLT) using 177Lu-PSMA is a promising treatment option. In addition, more information could be provided by subsequent investigative studies in the field of RLT.

The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA Keywords:

Prostatic neoplasms , Neoplasm Metastasis , Radionuclide therapy , 177Lu-PSMA , Radioligand therapy

The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA authors

Hojjat Ahmadzadehfar

Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany|Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Kamran Aryana

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Elahe Pirayesh

Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Saeed Farzanehfar

Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Cornford P, Bellmunt J, Bolla M, Briers E, De Santis ...
Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, ...
Haberkorn U, Eder M, Kopka K, Babich JW, Eisenhut M. ...
Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, ...
Kratochwil C, Giesel FL, Eder M, Afshar-Oromieh A, Benešová M, ...
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, ...
Mier W, Kratochwil C, Hassel JC, Giesel FL, Beijer B, ...
van der Zwan WA, Bodei L, Mueller-Brand J, de Herder ...
Bodei L, Kidd M, Paganelli G, Grana CM, Drozdov I, ...
Deb N, Goris M, Trisler K, Fowler S, Saal J, ...
Tagawa ST, Milowsky MI, Morris M, Vallabhajosula S, Christos P, ...
Bander NH, Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, ...
Vallabhajosula S, Goldsmith SJ, Hamacher KA, Kostakoglu L, Konishi S, ...
Vallabhajosula S, Goldsmith SJ, Kostakoglu L, Milowsky MI, Nanus DM, ...
Maresca KP, Hillier SM, Femia FJ, Keith D, Barone C, ...
Zechmann CM, Afshar-Oromieh A, Armor T, Stubbs JB, Mier W, ...
Kam BL, Teunissen JJ, Krenning EP, de Herder WW, Khan ...
Afshar-Oromieh A, Haberkorn U, Zechmann C, Armor T, Mier W, ...
Ahmadzadehfar H, Rahbar K, Kürpig S, Bögemann M, Claesener M, ...
Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, ...
Rahbar K, Schmidt M, Heinzel A, Eppard E, Bode A, ...
Ferdinandus J, Eppard E, Gaertner FC, Kürpig S, Fimmers R, ...
Yordanova A, Becker A, Eppard E, Kürpig S, Fisang C, ...
Ahmadzadehfar H, Zimbelmann S, Yordanova A, Fimmers R, Kürpig S, ...
Rahbar K, Bode A, Weckesser M, Avramovic N, Claesener M, ...
Ahmadzadehfar H, Wegen S, Yordanova A, Fimmers R, Kürpig S, ...
Bräuer A, Grubert LS, Roll W, Schrader AJ, Schäfers M, ...
Delker A, Fendler WP, Kratochwil C, Brunegraf A, Gosewisch A, ...
Schlenkhoff CD, Gaertner F, Essler M, Schmidt M, Ahmadzadehfar H. ...
Ahmadzadehfar H, Eppard E, Kürpig S, Fimmers R, Yordanova A, ...
Braat AJAT, Ahmadzadehfar H. Lutetium-177 labelled PSMA ligands for the  ...
Fendler WP, Kratochwil C, Ahmadzadehfar H, Rahbar K, Baum RP, ...
Budäus L, Leyh-Bannurah SR, Salomon G, Michl U, Heinzer H, ...
Kulkarni HR, Singh A, Schuchardt C, Niepsch K, Sayeg M, ...
Kratochwil C, Giesel FL, Stefanova M, Benešová M, Bronzel M, ...
Baum RP, Kulkarni HR, Schuchardt C, Singh A, Wirtz M, ...
Okamoto S, Thieme A, Allmann J, D Alessandria C, Maurer ...
Kabasakal L, AbuQbeitah M, Aygün A, Yeyin N, Ocak M, ...
Yordanova A, Becker A, Eppard E, Kürpig S, Fisang C, ...
Emmett L, Willowson K, Violet J, Shin J, Blanksby A, ...
نمایش کامل مراجع